(Monday - Friday 8.30am - 5pm)

gaitQ and machineMD secure million dollar research grant

Green line

gaitQ and machineMD secure million dollar research grant to monitor Parkinson’s development in the UK and Switzerland

  • 18-month research project will record digital biomarkers to better predict Parkinson’s Disease
  • Jointly funded by InnovateUK and Innosuisse, the research will collect data from 100 people with Parkinson’s
  • Research helps understand disease progression to enable earlier diagnosis

11th April 2024: Oxford-based medical technology start-up gaitQ® and Swiss medical device company machineMD today announce the joint award of a million dollar research grant from InnovateUK and Innosuisse to enable the collection and analysis of critical movement data from people with Parkinson’s (PwP).

The grant will fund an 18-month research project that will record movement data from 100 UK and Swiss PwP as they go about their daily lives, to help more effectively monitor the development of the disease.

The data will be used to establish patterns of behaviour and provide clinicians with insight to deliver more effective treatment plans, ultimately helping earlier detection and treatment of the condition. The data will be collected and analysed at University of Exeter (UoE) and University Hospital Zurich (USZ).

This grant – announced on World Parkinson’s Day (11th April) – marks a significant moment for the 10 million people worldwide living with Parkinson’s; a number that is expected to double by 2030. Parkinson’s is a complex movement condition with significant variation in disease progression across individuals. By mapping these biomarkers in movement, gaitQ and machineMD hope to identify critical moments in the development of Parkinson’s and unlock insight into better treatment.

Dr Tristan Collins, CEO at gaitQ®, comments: “Typically, Parkinson’s can develop at a different pace in different individuals and therefore the impact varies hugely. This research identifies key moments when the condition progresses and aims to understand more about what causes this and why. This can help clinicians and specialist physiotherapists create more relevant and personalised treatment plans, ultimately helping PwP manage their condition more independently and effectively.”

Dr Ana Coito, Neuroscientist at machineMD, explains: “People with Parkinson’s may remain asymptomatic from motor symptoms until 50-60% of the dopaminergic neurons have been lost and treatment is only initiated in the late disease phase. Early and accurate diagnosis as well as accurate disease progression monitoring, are still important challenges. Abnormal oculo-motor function has been reported in 75-87.5% of Parkinson’s patients. Through this research grant, we aim to identify valuable digital biomarkers, which may aid more accurate disease monitoring – opening new possibilities for timely treatment and personalized therapeutic strategies.”

Business Support News – Grassroots

We were pleased to announce the introduction of dedicated Business Support to the members of Grassroots workspace in central Oxford in January 2024. Wendy Tindsley, Innovation Director, whose wealth of knowledge

Read More »

Oxfordshire Inclusive Economy Partnership

The Oxfordshire Inclusive Economy Partnership (OIEP) is a county-wide group that brings together private, office space, public, voluntary and community sector organisations with an aim to collaborate to address the

Read More »

Ready to put down roots?

Find out more about Oxford’s most exciting workspace for science and technology start-ups.

Book a Tour

Put down roots in a well-established business community of science and technology innovators.

  • Book a tour of Grassroots
  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office or meeting space
Monday – Friday 8:30am -5pm
Name
Hidden
GDPR